Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respirat...
View Top Employees from Okairos AGWebsite | http://www.okairos.com |
Revenue | $7 million |
Employees | View employees |
Founded | 2007 |
Address | Aeschenvorstadt 71, Basel, Basel-City 4051, CH |
Phone | +41 61 270 35 35 |
Technologies | |
Industry | Pharmaceuticals, Biotechnology, Biopharma, Healthcare, Health Care, Drug Manufacturing & Research, Science and Engineering, Genetics, Medical, Pharmaceutical |
SIC | SIC Code 2834 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Okairos AG employee's phone or email?
The Okairos AG annual revenue was $7 million in 2024.
Okairos AG is based in Basel, Basel-City.
The NAICS codes for Okairos AG are [32541, 3254, 32, 325].
The SIC codes for Okairos AG are [2834, 283, 28].